OBJECTIVES: Despite recent advances in ERAS protocols for gynecologic surgery, there is little guidance on the clinical significance of postoperative voiding prior to discharge in the minimally invasive setting. The objective of this study was to determine if there is a significant difference in re-admission when patients are not required to void prior to discharge following a same-day gynecologic procedure. MATERIALS AND METHODS: After obtaining Institutional Review Board approval, we performed a retrospective comparison of patients undergoing outpatient gynecologic surgery from January 2015 to October 2017. Women who had procedures performed in pregnancy, concomitant urologic procedures, and invasive cancers were excluded. Patient charts were reviewed for the presence or absence of an order for the patient to spontaneously void prior to discharge, emergency room visits and re-admission within 30 days, and time to discharge in the post-anesthesia recovery unit. RESULTS: A total of 4743 patients undergoing same-day procedures were identified. There was no statistically difference in the readmission rate between patients with or without an order to void prior to discharge (0.4% versus 0.9%, p ¼ 0.08). Only three patients were re-admitted for urinary retention (all with an order to void prior to discharge). Compared to benign gynecologic surgeons, gynecologic oncologists were 23% more likely to place an order to void prior to discharge. Patients with an order to void spent approximately 59 minutes more in PACU than those without (p <0.001). CONCLUSION: Discharge without an order to void is a safe practice in patients undergoing same-day gynecologic procedures. The risk of post-discharge urinary retention is minimal, consistent with previously reported rates in the literature. In addition, practice patterns are influenced by the surgeon type. Given the apparent absence of increased rates of re-admission, omitting an order to void is potentially a cost-saving measure.
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45 Opiate use is associated with increased risk of treatment failure when using antimuscarinics for overactive bladder 
MATERIALS AND METHODS:
We performed a retrospective nested cohort analysis of patients being treated with antimuscarinic medication for overactive bladder between January 2010 and December 2017. We included patients who were prescribed an antimuscarinic and subsequently had clear documentation of adherence and response to treatment. The primary outcome was reported treatment failure. Patients who were currently on opiates at the time of treatment were matched by age to controls without an opiate prescription within 1 year of antimuscarinic treatment at a ratio of 1:3. Differences between groups were evaluated using Wilcoxon Rank-Sum and Fisher's exact test where appropriate. Logistic regression was used to control for confounders and identify predictors of the primary outcome. RESULTS: We identified 480 patients who met inclusion criteria. Opiate users were more likely to report constipation, have a remote history of urogynecologic surgery, a diagnosis of depression or anxiety, and to report treatment failure after taking antimuscarinic medication for overactive bladder (64.2% vs 48.1%, p¼0.02). After controlling for confounders, opiate use was predictive of antimuscarinic treatment failure (aOR 1.9, 95% CI 1.17-3.06). Treatment failure was also correlated with active central nervous system disease, number of incontinence episodes per day, number of nighttime voids, and number of previously failed antimuscarinic medications. CONCLUSION: Opiate use is associated with an increased risk of treatment failure when using antimuscarinic medications for overactive bladder.
